Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2005
08/04/2005WO2005049866A3 Methods of detecting charcot-marie tooth disease type 2a
08/04/2005WO2005045435A3 METHOD FOR DISTINGUISHING T(11q23)/MLL-POSITIVE LEUKEMIAS FROM T(11q23)MLL NEGATIVE LEUKEMIAS
08/04/2005WO2005045432A3 Method for distinguishing prognostically definable aml
08/04/2005WO2005044859A3 Cd20 antibodies with increased fc receptor binding affinity and effector function
08/04/2005WO2005043164A3 Method for distinguishing cbf-positive aml subtypes from cbf-negative aml subtypes
08/04/2005WO2005043163A3 Method for distinguishing who classified aml subtypes
08/04/2005WO2005043109A3 Sers diagnostic platforms, methods and systems including microarrays, biosensors and biochips
08/04/2005WO2005042771A3 Colorimetric substrates, colorimetric sensors, and methods of use
08/04/2005WO2005042715A3 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
08/04/2005WO2005041750A3 Method for identifying compounds that affect expression of tryptophan hydroxylase isoform 2
08/04/2005WO2005035715A8 Flanking dna sequences that control expression in the human genome
08/04/2005WO2005035711A3 Culture medium for rapid detection of mycobacterial growth by color change
08/04/2005WO2005027723A3 Real time assay for rotavirus
08/04/2005WO2005024040A3 Target and method for inhibition of bacterial rna polymerase: minimized derivatives of peptide antibiotic mccj25
08/04/2005WO2005018414A3 Detection of somatic cells in milk
08/04/2005WO2005016954A3 Immunologic activity measure(s) for t “helper” on-associated conditions
08/04/2005WO2005015155A3 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
08/04/2005WO2005012574A3 Biological bar-code
08/04/2005WO2005001059A3 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
08/04/2005WO2004108009A3 Method and kit for assessing risk for bovine respiratory disease
08/04/2005WO2004092360A3 The severe acute respiratory syndrome coronavirus
08/04/2005WO2004090547A3 Metastatic colorectal cancer signatures
08/04/2005WO2004089295A3 Homogeneous and heterogeneous assay methods using nucleation centers and novel covalent chemistries for the rapid measurement of phosphorylation and de-phosphorylation
08/04/2005WO2004087070A3 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-FUNGAL AGENTS
08/04/2005WO2004080273A3 Compositions and methods for diagnosing and treating prostate cancer
08/04/2005WO2004073651A3 Identifying inhibitors of intracellular protein fibrillization
08/04/2005WO2004072240A3 Antiplasmin cleaving enzyme
08/04/2005WO2004064782A3 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
08/04/2005WO2004046309A3 Methods for inhibiting viral replication in vivo
08/04/2005WO2004043238A3 Biomarkers for intra-amniotic inflammation
08/04/2005WO2004031413A9 Method for diagnosing non-small cell lung cancers
08/04/2005WO2004025266A3 Method and apparatus for sorting particles
08/04/2005WO2004016726A9 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
08/04/2005WO2004003220A3 Methods and composition for analyzing compromised samples using snps
08/04/2005WO2003095610A3 Directed evolution method of generating enhanced folding polypeptide variants
08/04/2005WO2003067217A3 Skin cell biomarkers and methods for identifying biomarkers using nucleic acid microarrays
08/04/2005WO2003062173A3 Alanine 2,3- aminomutase
08/04/2005US20050172375 Birch tree name 'verdale'
08/04/2005US20050172363 Nematode PPPT-like sequences
08/04/2005US20050172352 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/04/2005US20050172350 Identifying modulators of purine/pyrimidine phosphoribosyl transferase (PPPT) polypeptides; treating and preventing microorganismal infection in crop plants
08/04/2005US20050172345 Recombinant cells comprising muscarinic acetylcholine receptor 6 for use in identifying modulators for prevention and treatment of muscle, eating and nervous system disorders
08/04/2005US20050172343 Astrocyte modulated genes and uses thereof
08/04/2005US20050171338 Mammalian tribbles signaling pathways and methods and reagents related thereto
08/04/2005US20050171069 Methods and reagents for the treatment of multiple sclerosis
08/04/2005US20050171047 Immunostimulatory nucleic acid molecules
08/04/2005US20050171043 Methods and compositions for modulating mitochondrial aldehyde dehydrogenase-2
08/04/2005US20050171041 Identifying drug targets; assaying for expression of candidate ribonucleic acid in RNAi pathway molecule and svRNA
08/04/2005US20050171024 Modulating angiogenesis
08/04/2005US20050170526 Utilizing affinity capture to isolate the analytes and internal reference species (for quantification) followed by mass spectrometric analysis of the isolated analyte/internal reference species.
08/04/2005US20050170517 Materials for enhancing staining of biopolymers in matrices
08/04/2005US20050170500 Methods for identifying risk of melanoma and treatments thereof
08/04/2005US20050170447 Reagent combination and method for direct test strip measurement of cholesterol from low density lipoproteins at ambient temperatures
08/04/2005US20050170444 Detecting levels of free placental growth factor in urine samples; enzyme-lined immunosorbent assay, fluorescence polarization assay, or a colorimetric assay
08/04/2005US20050170442 Bimolecular optical probes
08/04/2005US20050170440 Treatment and diagnosis of insulin-resistant states
08/04/2005US20050170437 Methods and compositions relating to modulating amyloid precursor protein cleavage
08/04/2005US20050170434 Modulators of lymphocyte activation, mkk3b compositions and methods of use
08/04/2005US20050170430 Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/ca2+ signaling pathway
08/04/2005US20050170427 For activated slides for preparing microarrays of nucleic acids; solid phase synthesis
08/04/2005US20050170425 Hybridizing microorganism cDNA with probes linked to magnetic bead within tube, transferring to magnetic wells for washing, adding blocking solution, adding avidin enzyme complex or streptavidin enzyme complex, rewashing, suspending magnetic beads, and detecting luminescence or color change; kits
08/04/2005US20050170423 Systems and methods for transgenic and targeted mutagenesis screening
08/04/2005US20050170422 Using denaturation and primer specific amplification to ehance concentration of prferential biopolymer sequences; genomic analysis
08/04/2005US20050170418 Fluid distribution apparatus for separation of preferential biopolymers
08/04/2005US20050170417 A mutated G-CSF protein having a deletion of an amino acid sequence corresponding to an exon 3 region for use as a diagnostic cancer marker.
08/04/2005US20050170416 Accurate, economical and simple diagnosis of a variety of cancers based on the finding that exon 3 skipping occurs during transcription of the G-CSF gene in cancer patients
08/04/2005US20050170414 Reagents and methods useful for detecting diseases of the gastrointestinal tract
08/04/2005US20050170413 Transport peptide amino acid sequences for use in identifying modulators for prevention and treatment of cell proliferative disorders; tissue target therapy; drug delivery
08/04/2005US20050170412 Microarray for detection of sequence anomalies in preferential genes; genomics
08/04/2005US20050170411 Genes and proteins involved in the biosynthesis of enediyne ring structures
08/04/2005US20050170408 Recombinant g protein coupled receptor for use in identifying modulators for prevention and treatment of cell proliferative disorders
08/04/2005US20050170407 Reagents and methods useful for detecting diseases of the lung
08/04/2005US20050170406 Using Burkitt's lymphoma-172 nucleotide sequences as diagnostic, prognostic and imaging tool in detection and treatment of infection and cell proliferative disorders of urogenital system
08/04/2005US20050170405 Sensor and detecting method
08/04/2005US20050170404 Modified human growth hormone polypeptides and their uses
08/04/2005US20050170402 Method of separating substance from liquid
08/04/2005US20050170401 Hybridization apparatus and method
08/04/2005US20050170400 Using colorimetric analysis to determine positioning of coded beads in capillary system; biochips for biopolymer detection
08/04/2005US20050170396 Using monoclonal antibodies to determine concentration of preferential membrane bound receptor in cancer cells; immunoassay
08/04/2005US20050170394 GLUT1 transporters expressed in blood brain barrier cells
08/04/2005US20050170392 OAT3 transporters expressed in blood brain barrier cells
08/04/2005US20050170390 MCT1 transporters expressed in blood brain barrier cells
08/04/2005US20050170388 Pyrimidine nucleobases
08/04/2005US20050170387 Gout related genetic locus
08/04/2005US20050170386 Method of classifying gene expression strength in lung cancer tissues
08/04/2005US20050170385 Artificial receptors including gradients
08/04/2005US20050170380 Ribosomal protein for treatment, diagnosis and prevention of cell proliferative, atherosclerotic and nervous system disorders
08/04/2005US20050170379 Using genic variation to generate preferential therpeutics; bioinformatics; computtation models for rational drug design
08/04/2005US20050170378 Using comparative genomic hybridization to co-analyze DNA copy number and gene expression data to identify significant relationships between alterations in genomic sequence and genic function; genomics; proteomics; bioinformatics
08/04/2005US20050170377 Anticode oligomer for prevention and treatment of cell proliferative disorders; antitumor, antisense, antiproliferative agents
08/04/2005US20050170376 Combinatorial chemistry
08/04/2005US20050170375 Methods for enhancing gene expression analysis
08/04/2005US20050170373 Expression profiling using microarrays
08/04/2005US20050170372 Using computer systems monitor, categorize and classify genetic, protein and metabolic components of cell systems; proteomics; genomics; bioinformatics
08/04/2005US20050170370 Microarray comprising immobilized primers for monitoring RNA expression; transcrptional analysis
08/04/2005US20050170369 Methods for diagnosing a genetic risk for bone loss
08/04/2005US20050170368 Tumor-associated antigenic target polypeptides for use as tools in treatment of cell proliferative disorders; antitumor and/or antiproliferative agents
08/04/2005US20050170367 For polymerase screening
08/04/2005US20050170363 For conjugation with biomolecules, drugs, and toxins
08/04/2005US20050170362 Reduction of migration shift assay interference
1 ... 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 ... 3003